Osteitis fibrosa cystica as a clinical manifestation of secondary hyperparathyroidism
PDF (Español (España))

Keywords

Calcium
Calcitriol
Parathyroid glands
Hyperparathyroidism
Parathyroid Hormone
Parathyroidectomy
Osteitis fibrosa cystica
Vitamin D
Cysts

How to Cite

Nieva Flórez, A. C. ., Vallejo Serna, R. A. ., & Murcia Caicedo, J. C. . (2024). Osteitis fibrosa cystica as a clinical manifestation of secondary hyperparathyroidism. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 11(1). https://doi.org/10.53853/encr.11.1.821

Abstract

Introduction: Brown tumors are a localized form of osteitis fibrosa cystica, which is a non neoplastic complication of hyperparathyroidism (HPT), hystologically characterized for the substitution of osteocytes by fibrous tissue. These lesions can appear anywhere along the bone skeleton, more frequently in long bones, and less frequently in ribs, pelvis and facial bones. However, most patients with these kind of lesions in unusual localizations, are initially wrongly diagnosed and their chances of getting an early treatment are diminished.

Purpose: Contribute to awareness of this manifestation to accomplish the right identification, diagnosis, and early approach of these patients, diminishing the risk of developing complications.

Case presentation: 22 year old patient, with chronic kidney disease (CKD), who consult with refractory hyperparathyroidism, with an expansive palatal lesion, configuring an unusually localized osteitis fibrosa, surgically intervened with subtotal parathyroidectomy, which was insufficient for patient’s hyperparathyroidism and its established complications.

Discussion: In patients with CKD, synthesis of calcitirol and calcium’s reabsorption are affected as a consequence to the loss of functional kidney tissue. In order to keep the regulation of serum levels of calcium and phosphorus, parathyroid’s activity is increased and so is the synthesis of parathyroid hormone, which stimulates bone resorption. Once bone resorption becomes persistent, it leads to the development of osteitis fibrosa cystica, one of the manifestations of Bone Mineral Disease, a systemic complication of hyperparathyroidism.

Conclusion: Brown tumors are a consequence of advanced HPT, which is why medical staff should be educated in the course of HPT in patients with CKD, and develop skills to recognize its complications in order to favor early diagnosis and treatment.

https://doi.org/10.53853/encr.11.1.821
PDF (Español (España))

References

Aragón Valera C, Carrasco de la Fuente M, Alpañés Buesa M, Sanchón Rodríguez R, et al. Osteítis fibrosa quística como manifestación inicial de hiperparatiroidismo primario. Endocrinol y Nutr. 2009;56(3):140-142. https://doi.org/10.1016/S1575-0922(09)70845-9

Aroca-Martínez G, Serna-Otero MD, Almanza-Hurtado A, Molina R, et al. Tumor pardo en paladar duro como primera manifestación de hiperparatiroidismo secundario. Rev Electron Biomed. 2018;2:29. https://biomed.uninet.edu/2018/n2/aroca.pdf

Quevedo-Vélez C, Castaño-Lopera V, Espinosa-De La Ossa C, Moncayo-Viveros JG, Builes-Montaño CE. Tumor pardo espinal como primera manifestación de un hiperparatiroidismo primario: revisión sistemática de la literatura y reporte de un caso. Rev Colomb Endocrinol Diabet Metab. 2017;4(3):20-24. https://doi.org/10.53853/encr.4.3.132

Araya I, Yanine N, Cornejo M, Villanueva J. Tumor pardo maxilar refractario a tratamiento convencional. Rev Espanola de Cirugía Oral y Maxilofac. 2014;36(1):21-26. https://doi.org/10.1016/j.maxilo.2012.01.005

Can Ö, Boynue?ri B, Gökçe AM, Özdemir E, et al. Brown Tumors: A Case Report and Review of the Literature. Case Rep Nephrol Dial. 2016;6(1):46-52. https://doi.org/10.1159/000444703

Alcaide Lucena M, Hernández García E, Reyes Lartartegui S, Gallart Aragón T, et al. Hiperparatiroidismo secundario. Actualización y revisión bibliográfica. Cir Andal. 2020;31(3):294-299. https://doi.org/10.37351/2020313.11

Xu B, Yu J, Lu Y, Han B. Primary hyperparathyroidism presenting as a brown tumor in the mandible: a case report. BMC Endocr Disord. 2020;20(1):6. https://doi.org/10.1186/s12902-019-0480-2

Parisien M, Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. Bone disease in primary hyperparathyroidism. Endocrinol Metab Clin North Am. 1990;19(1):19-34. https://doi.org/10.1016/S0889-8529(18)30337-2

Xie C, Tsakok M, Taylor N, Partington K. Imaging of brown tumours: a pictorial review. Insights Imaging. 2019;10(1):75. https://doi.org/10.1186/s13244-019-0757-z

Alemán?Iñiguez J, Mora?Bravo F, Bravo?Aguilar C. Rara localización de tumor pardo en insuficiencia renal crónica. Reporte de un caso pediátrico y actualización. Rev. port. endocrinol. diabetes metabol.. 2016;11(2):220-227. https://doi.org/10.1016/j.rpedm.2016.04.001

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2024 Revista Colombiana de Endocrinología, Diabetes & Metabolismo

Dimensions


PlumX


Downloads

Download data is not yet available.